Head of Portfolio and Program Management, Sanofi Generics @ (June 2016 - September 2017)
Operation Excellence and Innovation Director @ (October 2015 - May 2016)
Head Business Development Europe @ (May 2014 - September 2015)
Portfolio Building Director @ (April 2012 - April 2014)
Head Portfolio Management API @ (October 2008 - April 2012)
Sector Head Chemical Development @ (October 2006 - September 2008)
Lab Head Chemical Development @ (February 2004 - September 2006)
Martin Albert Education
Max-Planck-Institut Mühlheim 2001-2002
Technische Universität Graz
Dr. (Technische Chemie)
1990-2000
Université de Rennes I
(Chemie)
1995-1995
Martin Albert Skills
Portfolio Management
API Development
Strategy
Generic Drugs
Pharmaceutical Industry
Product Lifecycle Management
Business Analysis
Process Optimization
Business Portfolio Management
Project Management
Processes Development
Business Development
Portfolio Development
Chemical Synthesis
Business Strategy
Regulatory Affairs
GMP
Technology Transfer
Pharmaceutics
Arzneimittelverkauf
Biotechnologie
Pharmazeutik
Arzneimittelzulassung
Strategisches Management
Technologietransfer
Pharmaindustrie
Unternehmensstrategie
Generische Programmierung
Strategie
Engineering
Microsoft Excel
Strategic Planning
Program Management
JavaScript
Business Portfolio
Product Lifecycle
Leadership
Martin Albert Summary
Martin Albert, based in Prague, Czechia, is currently a Chief Scientific Officer at Zentiva. Martin Albert brings experience from previous roles at Sanofi, Glenmark Pharmaceuticals and Zentiva (a Sanofi Company). Martin Albert holds a 2001 - 2002 Max-Planck-Institut Mühlheim. With a robust skill set that includes Portfolio Management, API Development, Strategy, Generic Drugs, Pharmaceutical Industry and more. Martin Albert has 1 emails on RocketReach.
Looking for a different Martin Albert?
Find contact details for 700 million professionals.